Final analysis of a phase II trial of neoadjuvant chemoimmunotherapy for locoregionally advanced head and neck squamous cell carcinoma.
Zhao X, Zhou Y, Peng G, Wen L, Hong X, Hu Y, Wu B, Liu X, Zhang Z, Xiao G, JingHuang, Ding Q, Yang C, Xiong X, Ma H, Shi L, Yang J, Wei J, Qin Y, Wan C, Zhong Y, Leng Y, Zhang T, Wu G, MinYao, Jia Y, Zhang X, Yang K.
Zhao X, et al. Among authors: wu g, wu b.
Oral Oncol. 2024 Sep;156:106918. doi: 10.1016/j.oraloncology.2024.106918. Epub 2024 Jun 28.
Oral Oncol. 2024.
PMID: 38943870
Clinical Trial.